Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
14,56 USD | +1,32% | -6,73% | +51,35% |
26/04 | MACROGENICS, INC. : B. Riley ancora positivo | ZM |
09/04 | MACROGENICS, INC. : TD Cowen ha un'opinione positiva | ZM |
Attività
Numero di dipendenti: 339
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Collaborative and Other Agreements
49,3
%
| 119 | 78,5 % | 29 | 49,3 % | -75,70% |
Monoclonal Antibody-based Therapeutics
30,5
%
| 17 | 11,0 % | 18 | 30,5 % | +7,25% |
Contract Manufacturing
16,7
%
| 14 | 9,2 % | 10 | 16,7 % | -29,70% |
Government Agreements
2,6
%
| 2 | 1,3 % | 2 | 2,6 % | -19,08% |
Royalty
0,7
%
| - | - | 0 | 0,7 % | - |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 152 | 100,0 % | 59 | 100,0 % | -61,33% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Scott Koenig
FOU | Founder | 71 | 14/08/00 |
James Karrels
DFI | Director of Finance/CFO | 57 | 01/05/08 |
Stephen Eck
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/07/20 |
Eric Risser
COO | Chief Operating Officer | 51 | 01/03/09 |
Ezio Bonvini
CTO | Chief Tech/Sci/R&D Officer | 70 | 01/06/03 |
Jeffrey Peters
LAW | General Counsel | 53 | 01/08/15 |
Corporate Officer/Principal | 57 | 01/01/13 | |
Lynn Cilinski
AUD | Comptroller/Controller/Auditor | 66 | 01/10/03 |
Syd Johnson
PRN | Corporate Officer/Principal | - | 01/01/01 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Margaret Liu
BRD | Director/Board Member | 66 | 03/01/23 |
David Stump
BRD | Director/Board Member | 74 | 19/09/13 |
Edward Hurwitz
BRD | Director/Board Member | 60 | 01/10/04 |
William Heiden
CHM | Chairman | 64 | 22/05/22 |
Scott Jackson
BRD | Director/Board Member | 60 | 25/01/17 |
Scott Koenig
FOU | Founder | 71 | 14/08/00 |
Federica O’Brien
BRD | Director/Board Member | 66 | 10/02/21 |
Director/Board Member | 51 | 03/01/23 | |
Karen Ferrante
BRD | Director/Board Member | 66 | 25/01/17 |
Jay Siegel
BRD | Director/Board Member | 71 | 13/11/17 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 62 560 502 | 60 313 787 ( 96,41 %) | 0 | 96,41 % |
Coordinate società
MacroGenics, Inc.
9704 Medical Center Drive
20850-3368, Rockville
+301 251 5172
http://www.macrogenics.comSettore
Vendite per attività
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+51,35% | 911 Mln | |
-2,31% | 103 Mrd | |
+0,56% | 95,28 Mrd | |
+1,69% | 22,15 Mrd | |
-17,37% | 21,02 Mrd | |
-9,30% | 18,15 Mrd | |
-41,01% | 16,74 Mrd | |
-14,85% | 16,05 Mrd | |
+3,21% | 13,68 Mrd | |
+33,54% | 12,17 Mrd |
- Borsa valori
- Azioni
- Azione MGNX
- Società MacroGenics, Inc.